Profile	GDS4460 / 227747_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	1140.4	96
GSM803589	patient 7, baseline	882.8	95
GSM803592	patient 8, baseline	487.8	90
GSM803595	patient 10, baseline	744.7	94
GSM803598	patient 11, baseline	1497.3	97
GSM803601	patient 12, baseline	752.9	94
GSM803604	patient 13, baseline	679.4	93
GSM803607	patient 14, baseline	759.3	93
GSM803610	patient 15, baseline	880.9	94
GSM803613	patient 16, baseline	1003.9	95
GSM803587	patient 6, arm treated with pimecrolimus	1314.5	96
GSM803590	patient 7, arm treated with pimecrolimus	907.4	95
GSM803593	patient 8, arm treated with pimecrolimus	1095.2	96
GSM803605	patient 13, arm treated with pimecrolimus	1430.2	97
GSM803608	patient 14, arm treated with pimecrolimus	669	92
GSM803599	patient 11, arm treated with pimecrolimus	968.7	95
GSM803611	patient 15, arm treated with pimecrolimus	989	95
GSM803614	patient 16, arm treated with pimecrolimus	1087.1	96
GSM803602	patient 12, arm treated with pimecrolimus	922.7	95
GSM803596	patient 10, arm treated with pimecrolimus	519.5	91
GSM803591	patient 8, arm treated with betamethasone	992.8	95
GSM803609	patient 15, arm treated with betamethasone	565.1	91
GSM803597	patient 11, arm treated with betamethasone	1054.7	96
GSM803585	patient 6, arm treated with betamethasone	811.6	94
GSM803603	patient 13, arm treated with betamethasone	678.9	93
GSM803612	patient 16, arm treated with betamethasone	953.2	95
GSM803588	patient 7, arm treated with betamethasone	541.1	91
GSM803594	patient 10, arm treated with betamethasone	639	92
GSM803600	patient 12, arm treated with betamethasone	808.7	94
GSM803606	patient 14, arm treated with betamethasone	967.1	95